Genzyme

Part of Sanofi (Wikidata)

CompanyUnited StatesFounded 1981

Genzyme develops one asset, in phase 3 (Orthovisc in aesthetic). Mostly other acting on CD44; based in the United States, founded in 1981.

1
Asset
Furthest: Phase 3; 13
Trials: 0
Signals

Pipeline

1

Orthovisc
Dermal filler providing structural support and tissue augmentation
Phase 3, Other, CD44, aesthetic, facial aesthetic treatment

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms2
Trials48
Similar companies3

Updated 12 Oct 2026 · 62 sources